Unitaid
roomChemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland
arrow_backSee all Activities

Improving Severe Malaria Outcomes by strengthening the market for severe malaria treatment (injectable and intrarectal artesunate) and analyzing market potential for pre-referral treatment

IATI Identifier: XM-DAC-30010-utd-mmv_as
Published in IATI IATI
  • date_range Jun 05, 2013 - Jun 05, 2016
  • autorenew Finalisation (Status)

The goal of this project led by MMV in collaboration with CHAI and Malaria Consortium is to contribute to the reduction in mortality from severe malaria through the accelerated global adoption of injectable artesunate and availability of artesunate suppository

more_horiz

Participating Organisations

Organisation Name Organisation Type Organisation Role
Medicines for Malaria Venture (MMV) Private Sector Implementing

Transaction

Transaction Value Provider Receiver Type Date
840,728 USD (Valued at Dec 31, 2016) circle Provider N/A circle Receiver N/A Disbursement date_rangeDec 31, 2016
8,483,616 USD (Valued at Dec 31, 2015) circle Provider N/A circle MMV Disbursement date_rangeDec 31, 2015
1,241,557 USD (Valued at Dec 22, 2014) circle Provider N/A circle MMV Disbursement date_rangeDec 22, 2014
4,844,156 USD (Valued at Aug 06, 2014) circle Provider N/A circle MMV Disbursement date_rangeAug 06, 2014
573,000 USD (Valued at Jun 27, 2014) circle Provider N/A circle MMV Disbursement date_rangeJun 27, 2014
630,000 USD (Valued at May 31, 2014) circle Provider N/A circle MMV Disbursement date_rangeMay 31, 2014
3,420,000 USD (Valued at Sep 30, 2013) circle Provider N/A circle MMV Disbursement date_rangeSep 30, 2013
34,000,000 USD (Valued at Jun 05, 2013) circle Provider N/A circle MMV Commitment date_rangeJun 05, 2013

Budget

0 USD
access_timeUpdated on May 04, 2018 10:02:14
View XML file here